European Healthtech CEO Forum

A FreeMind Group Supported Event

When: February 28, 2022

FreeMind proudly supports the European Healthtech CEO Forum.

The 3rd annual European HealthTech CEO Forum (EHTF), will take place on the 28th of February 2022 and will be part of the Sachs Spring Life Sciences Week (SSLSW). SSLSW will also incorporate the 15th annual European Life Sciences CEO Forum.

EHTF will focus on investment and partnership in MedTech and Digital Health. The programme will feature topical keynotes and panels with industry leaders as well as around 20 corporate presentations by public, private and growth companies. 200+ delegates are anticipated, including major and growth corporates, financial investors/partners, bankers and advisors.

Virtual meetings will take place from February 28th through March 4th. The system will be open for 12 hours a day, and 1000+ meetings are expected. ​The conference will be held in the Central European Time Zone. The digital event will consist of:

HealthTech Innovation Day (Monday, 28th of February)

  • Pharma: Accelerating Digital Innovation Panel
  • Investing in Digital Health & Therapeutics Panel
  • European MedTech & Device Panel
  • Innovation & Early Stage Investment Panel
  • European Health Tech Startups Presented by EIT Health
Confirmed Keynote Speakers Include:
  • Eyal Zimlichman, Deputy Director General, CMO & CIO, Sheba Medical Center
  • Kurt Höller, Director of Business Creation, EIT Health e.V.
  • Raphaël Conz, Economic Promotion Manager, Office for Economic Affairs and Innovation (SPEI)
Confirmed Chairs & Speakers Include:
  • Adrien Clavairoly, Senior Associate , AdBio Partners
  • André Heeg, Managing Director & Partner, BCG Digital Ventures
  • Anne-Kathrin Witt, Global Head Digital BD&L, Novartis International AG
  • Assaf Barnea, CEO, Sanara Ventures Ltd.
  • Beatriz Volckaert, Senior Associate – Venture Investments, Philips Ventures
  • David Braun, Global Head of Connected Health & Devices Business Solutions, Merck Healthcare KGaA
  • David Gordon, Head of Investments, Longliv Ventures
  • Henry Zubaida, Senior Associate, Gilde Healthcare Partners
  • Judith Zilberstein, CEO , Alon MedTech Ventures
  • Kurt Höller, Director of Business Creation, EIT Health e.V.
  • Lloyd Diamond, President & CEO, PIXIUM VISION SA
  • Mark Andrews, Managing Director, PharmaVentures Ltd.
  • Martin Pfister, Principal/Prokurist, High-Tech Gründerfonds Management GmbH
  • Martin Rothman, Venture Partner, Sofinnova Partners*
  • Matthieu Merlin, Head Business Development – China & General Medicines, Sanofi
  • Mike Karim, CEO, Oxford Endovascular Ltd.
  • Nadine Hachach-Haram, Founder & CEO, Proximie Ltd.
  • Nawal Roy, Founder & CEO, Holmusk
  • Rana Lonnen, Managing Director, Novartis Pharma AG
  • Regina Hodits, Managing Partner, Wellington Partners Life Sciences (WPLS)
  • Samuel Levy, Founding Partner, Lauxera Capital Partners
  • Tamir Meiri, Director, Venture Investments, Johnson & Johnson Innovation – JJDC, Inc.*
  • Tanja Dowe, CEO, Debiopharm Innovation Fund SA
  • Thijs Cohen Tervaert, Junior Partner, INKEF Capital BV
  • Wilder Fulford, Founder & Managing Director, The Fulford Group Ltd.
  • Yaron Daniely, Partner at aMoon & the Head of aMoon Alpha